Streetbeat News

Revenues

LZ

LegalZoom.com (NASDAQ:LZ) received mixed ratings from 5 analysts, with all 5 showing a somewhat bullish stance. The average 12-month price target is $14.6, down from $15.50, indicating a 5.81% decrease. Analyst actions include maintaining, raising, and lowering ratings with price targets ranging from $14.00 to $16.00. LegalZoom.com's financial performance is strong, with notable revenue growth, high net margin, and excellent ROE and ROA, positioning it well in the Industrials sector.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 2:01 pm

WEX

WEX Inc (NYSE:WEX) has been analyzed by 7 analysts over the last three months, showing a mix of bullish to indifferent sentiments. The average 12-month price target is $241.29, marking a 9.68% increase from the previous target. Analysts from firms like Jefferies, Evercore ISI Group, Mizuho, Barclays, Truist Securities, and JP Morgan have raised their price targets, reflecting optimism about WEX's future performance. WEX operates in corporate payment solutions, showing solid revenue growth and profitability but faces challenges in asset utilization and debt management.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 2:00 pm

VIRC

Virco Mfg. Corporation (NASDAQ:VIRC) reported a 16.5% increase in full-year revenue to $269.1M for the fiscal year ended January 31, 2024. The company, a leading supplier of furniture for educational environments, also saw its gross margin improve to 43.1% from 36.9% in the prior year. Operating income surged to $31.9M from $10.6M, and net income after taxes rose to $21.9M from $16.5M. Virco's debt-free status, except for a small mortgage, and its vertically integrated business model were highlighted as key factors in its financial performance. The company's 'Shipments + Backlog' metric, a non-GAAP measure, exceeded $317.6M at year-end, indicating strong business velocity.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 1:04 pm

TRTX

Analysts have provided diverse opinions on TPG RE Finance Trust (NYSE:TRTX), with recent ratings ranging from bullish to bearish. The average 12-month price target is $7.38, reflecting a 13.54% increase from the previous target. Analysts from Raymond James, JP Morgan, B of A Securities, and Wells Fargo have updated their ratings and price targets, indicating varying expectations for TRTX's performance. The company, a commercial real estate finance entity, has shown a revenue growth of 6.95% but lags in net margin and ROE compared to industry averages.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 1:01 pm

CLH

Clean Harbors (NYSE:CLH) was analyzed by 9 financial analysts, showing a shift towards more bullish ratings in the last quarter with an increase in the 12-month price target to $213.44 from $194.00. The company's financial performance indicates strong profitability and efficient management, with a notable revenue growth rate of 4.7% as of December 31, 2023, and a high net margin of 7.35%. Analysts' actions, including rating upgrades and price target adjustments, reflect optimism about the company's market position and financial health.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 1:01 pm

OGS

Recent analyst ratings for ONE Gas (NYSE:OGS) show a mix of bullish and bearish perspectives, with a total of 5 analysts offering their evaluations over the past three months. The average 12-month price target for OGS has been raised to $60.9, up 4.1% from the previous target of $58.50. Analyst actions include both upgrades and initiations, with price targets ranging from $58.00 to $64.50. Despite the mixed analyst outlook, ONE Gas faces financial challenges, including a significant revenue decline of -25.95% as of December 31, 2023, and below-average profitability and efficiency metrics.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 1:00 pm

TH

Target Hospitality (NASDAQ:TH) has been analyzed by 4 analysts, showing a mix of ratings from bullish to indifferent. The average 12-month price target is now $12.00, down from $13.00, reflecting a 7.69% decline. Analyst actions include lowering and maintaining ratings, with price targets adjusted accordingly. The company's financial performance shows a revenue decline of -17.2% over 3 months, but it outperforms in net margin, ROE, and ROA, indicating strong financial health despite revenue challenges.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 1:00 pm

AMD

AVGO

INTC

MRVL

NVDA

QCOM

Despite US-China tensions, China remains a crucial market for U.S. semiconductor firms like Nvidia, Intel, Broadcom, Qualcomm, and Marvell Technology. These companies continue to report greater revenues from China than the U.S., even amid stringent export controls targeting AI-related chips. U.S. firms have adapted by developing modified AI chips for China to comply with regulations, while maintaining a technological lead. The Semiconductor Industry Association has called for a de-escalation of tensions, as China moves towards semiconductor self-reliance and the U.S. plans further restrictions on Chinese chipmaking facilities.

Portfolio Pulse from Benzinga Neuro

April 12, 2024 | 12:58 pm

C

Citigroup reported a mixed financial performance for Q1, with a 7% decline in Markets Revenue, a 35% increase in Investment Banking Revenue, a 4% decrease in Wealth Revenue, and a 10% rise in US Personal Banking.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 12:08 pm

PRTG

Portage Biotech Inc. (NASDAQ:PRTG) is expanding its strategic alternatives review and pausing further enrollment in the ADPORT-601 clinical trial to extend its cash runway. The company is exploring options including partnerships, asset sales, a company sale, mergers, restructurings, or a wind down. There's no assurance that this process will result in any agreements or successful transactions.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 12:06 pm